ALIPEX project - Press release of February 19th, 2014
DTF Medical is proud to announce you the 10 million euro support brought by BPI France to the ALIPEX program.
"The ALIPEX development program seeks to provide cystic fibrosis patients with a new-generation inhalation treatment that is efficient in fighting severe respiratory infections, including those that are resistant to antibiotics."
Download the press release.
